Pharmaceutical, Biopharmaceutical, and Bioanalysis Publications by Intertek

Read our pharmaceutical journal and industry publications for more insight from Intertek's pharma experts.

  • Analysis of mRNA Therapeutics and Vaccines. C. Challener, BioPharm International 35 (2) (2022). Contributor: Ashleigh Wake, Business Development Director, Intertek Pharmaceutical Services UK.
  • Eliminating Residual Impurities Starts with a Strategic Plan. C. Challener, BioPharm International 33 (7) 2020. Contributor: Ashleigh Wake, Business Development Director, Intertek Pharmaceutical Services UK.
  • Risky Business: Assessing Protein Aggregation Grows Increasingly Challenging. F. Mirasol, BioPharm International 33 (9) 2020. Contributor: Ashleigh Wake, Business Development Director, Intertek Pharmaceutical Services UK.
  • Drug Tolerance Assessment and Improvement in Cell Based NAb Assays Using Response Data Modeling. A. Nikolskaya, N. Ibrahim, F. Hosseini, N. Prigozhina, Intertek Pharmaceutical Services, San Diego, CA, USA. Poster presentation at the AAPS Annual Meeting and Exposition, November 12 – 15, 2017.
  • Use of LC-HRMS for Protein Analysis in Drug Development. Laurence M. Brill, Intertek Pharmaceutical Services, San Diego, CA, USA. Presentation at the AAPS Annual Meeting and Exposition, November 12 – 15, 2017. 
  • Drug Tolerance Improvement in Cell Based Neutralizing Antibody Assays Using Pharmacokinetic Assay Data. A. Nikolskaya, N. Ibrahim, F. Hosseini, N. Prigozhina, Intertek Pharmaceutical Services, San Diego, CA, USA. Poster presentation at the Immunogenicity and Bioassay Summit, October 24 – 27, 2017.
  • Development and Validation of Bioanalytical Methods in Ocular Matrices.
    Mike Buonarati, PhD, Senior Director, Intertek Pharmaceutical Services, San Diego, CA, USA. Presentation at the Applied Pharmaceutical Analysis (APA) Annual Meeting, September 18 - 20, 2017.
  • Feasibility of a 3D Spheroid Model System for Dynamic and End-Point Drug Testing Readouts.
    Natalie Prigozhina, PhD, Principal Investigator, Cell Based Assays, Intertek Pharmaceutical Services, San Diego, CA, USA. Poster presentation at the Applied Pharmaceutical Analysis (APA) Annual Meeting, September 18 – 20, 2017.
  • Versatile Enzyme Activity Assay of a PEGylated Cyst(e)inase in Mammalian Sera Using LC-MS/MS. Laurence M. Brill, PhD, Senior Scientist, Bioanalytical LCMS, Intertek Pharmaceutical Services, San Diego, CA, USA. Poster presentation at the ASMS Annual Conference, June 4 – 8, 2017.
  • Challenges in Developing Ocular Drugs from a Bioanalytical and Toxicological Perspective. Mike Buonarati, Senior Director, Bioanalytical LCMS, Intertek Pharmaceutical Services, San Diego, CA, USA; Lindsay N. Donald, DABT, Vice President, Pharmaceutical & Healthcare, Intertek Scientific & Regulatory Consultancy, Birmingham, AL, USA. Presentation at the SOT Annual Meeting and ToxExpo, March 12 – 16, 2017.
  • Total Unbound Cysteine/Cystine Assay in Monkey Plasma Using LC-MS/MS.
    L. Brill, M. Buonarati, and D. Schoener, Intertek Pharmaceutical Services, San Diego, CA, USA; Susan Alters, Aeglea Biotherapeutics, Austin, TX, USA; Everett Stone, University of Texas at Austin, Austin, TX, USA. Poster presentation at the MSACL Annual Conference, January 22 – 26, 2017.
Need help or have a question? +1 858 558 2599
 

Need help or have a question?

+1 858 558 2599
EMEA UK:
+44 161 721 5247